IP Library › Assignment 050021/0123
Patent Assignment
Reel/Frame 050021/0123

Assignment of Assignor's Interest

Recorded: 2019-08-12 Pages: 9
Assignors
HANLEY, DAVID CHRISTIAN
Executed: 2019-08-02
YOCCA, FRANK
Executed: 2019-08-02
LATHIA, CHETAN DALPATBHAI
Executed: 2019-08-02
Assignee
BIOXCEL THERAPEUTICS, INC.
555 LONG WHARF DRIVE, NEW HAVEN, CONNECTICUT, 06511
Covered Property (1)
Film Formulations Containing Dexmedetomidine and Methods of Producing Them
Application: 16/453,679 →
Publication: US 2020/0000717
Related Assignments (11)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 12, 2019
From: E.Z. BIOXCEL SOLUTIONS PVT. LTD.
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 050021/0158 →
Assignment of Assignor's Interest Aug 12, 2019
From: BARNHART, SCOTT DAVID
To: ARX, LLC
Reel/Frame 050021/0186 →
Assignment of Assignor's Interest Aug 12, 2019
From: KAKUMANU, VASUKUMAR
To: E.Z. BIOXCEL SOLUTIONS PVT. LTD.
Reel/Frame 050021/0151 →
Corrective Assignment to Correct the Signature Page by Assignee (Correcting Assignee Name to Ez Bioxcel Solutions Pvt. Ltd. Rather Than Bioxcel Therapeutics, Inc. Previously Recorded on Reel 050021 Frame 0151. Assignor(S) Hereby Confirms the Correct Assignee Name for Signature Is Ez Bioxcel Solutions Pvt. Ltd. Jan 12, 2021
From: KAKUMANU, VASUKUMAR
To: E.Z. BIOXCEL SOLUTIONS PVT. LTD.
Reel/Frame 054976/0212 →
Security Interest Apr 19, 2022
From: BIOXCEL THERAPEUTICS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 059727/0964 →
Security Interest Apr 19, 2022
From: BIOXCEL THERAPEUTICS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 059726/0788 →
Assignment of Assignor's Interest Feb 13, 2023
From: ARX, LLC
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 062678/0905 →
Assignment of Assignor's Interest Feb 16, 2023
From: ARX, LLC
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 062725/0182 →
Assignment of Assignor's Interest May 30, 2023
From: ARX, LLC
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 063789/0539 →
Corrective Assignment to Correct the Property Numbers and Remove Application Number 17/579,914 and Application Number 18/085,263 Previously Recorded at Reel: 063789 Frame: 0539. Assignor(S) Hereby Confirms the Assignment. Jun 7, 2023
From: ARX, LLC
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 064042/0592 →
Security Interest Sep 11, 2024
From: BIOXCEL THERAPEUTICS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 068938/0906 →